Jon K Ashby, PHD



Hearing and Speech Therapy   -  Texas,  Abilene

 Overview

Jon K Ashby, PHD works in Abilene, Texas is a specialist in Hearing and Speech Therapy, Speech Pathology / Therapy. 

 Specialties

  • Hearing and Speech Therapy
  • Speech Pathology / Therapy

 State License

  • Texas

 Education & Training

Education for Jon K Ashby, PHD are not present.

 Awards

Awards for Jon K Ashby, PHD are not present.

 Dr. Ashby Reviews

Reviews for Jon K Ashby, PHD are not present. Be the first to review this doctor!
 Add Review as registered PatientOR Add Review as Guest

 Office Locations


Primary location

 Office Address
6300 Regional Plaza
Texas (TX)
Abilene
79606
 Phone:(325) 698-9048

Accepting New Patients

  • No
* Please verify this information when scheduling an appointment.

 Map & Directions



Office Address, 6300 Regional Plaza, Abilene, Texas (TX), 79606




 Insurances Accepted (check insurance plans)

  • Blue Advantage HMO
  • Blue Card PPO
  • Blue Choice
  • Blue Cross Blue Shield
  • Blue Cross Blue Shield of Texas
  • Choice Plus POS
  • Navigate HMO
  • Navigate POS
  • Options PPO
  • UnitedHealthCare

* Please verify this information when scheduling an appointment.

 Blog Posts

Blog Posts for Jon K Ashby, PHD are not present.

 Patients Questions

Patients questions for Jon K Ashby, PHD are not present.

 Affiliated Hospitals

Affiliated hospitals for Jon K Ashby, PHD are not present.

  •  Latest reviews for Hearing and Speech Therapy specialists

  • Dr. C. is a pleasant, professional caring and fun doctor. Answered all my questions on a keep it simple level and explained everything. He took his time. I will refer them when needed. What a great group!
    07 February 2024
    (6)
  • He is the best if you need help with panic attacks. He fixed up my medication and I feel better.
    31 January 2024
    (40)
  • Dr. Jungblut and staff are all professional, fun, conscientious. Been going here for a long time. My children and grandchildren now see Dr. Jungblut too.
    24 January 2024
    (7)
Close
Sign Up / Login
Connect with Sign Up / Login